Prognostic value of urokinase plasminogen activator in primary breast carcinoma: comparison of two immunoassay methods.

Urokinase-type plasminogen activator (uPA) is a potentially important prognostic factor in breast cancer for identifying patients at high risk of recurrence. This retrospective study assessed two enzyme-linked immunosorbent assay (ELISA) methods measuring uPA antigen levels in 499 primary breast can...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouchet, C., Spyratos, F., Hacène, K., Durcos, L., Bécette, V., Oglobine, J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150205/
https://www.ncbi.nlm.nih.gov/pubmed/9652768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150205/
https://www.ncbi.nlm.nih.gov/pubmed/9652768

Ejemplares similares